HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure

18Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

In a recent summary of integrase sequences, primary integrase inhibitor mutations were rare. In a review of integrase inhibitor-naïve Australian HIV-1 sequences, primary mutations were not identified, although the accessory mutation G140S was detected. A link with previous antiretroviral therapy, intra-subtype B divergence across the integrase gene and transmission of integrase polymorphisms were also noted. Based on these findings, we would recommend ongoing surveillance of integrase mutations, and integrase region sequencing for patients prior to commencement of integrase inhibitors. © 2009 van Hal et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

van Hal, S. J., Herring, B., Deris, Z., Wang, B., Saksena, N. K., & Dwyer, D. E. (2009). HIV-1 integrase polymorphisms are associated with prior antiretroviral drug exposure. Retrovirology, 6. https://doi.org/10.1186/1742-4690-6-12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free